TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the American Academy of Neurology Annual Meeting

3 years ago

NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data from the ULTIMATE I & II…

Innovation1 Biotech (IVBT) Completes Name and Ticker Symbol Change from Gridiron BioNutrients (GMVP)

3 years ago

NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule…

Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency

3 years ago

- Rapid, significant, and sustained increase in plasma pyrophosphate (PPi) levels observed in all three patients in lowest dose cohort…

Citrix® Modernizes Security to Accommodate Hybrid Work

3 years ago

Company launches cloud delivered, Zero Trust Network Access solution that protects all apps, data and devices, enabling secure work from…

Patient Safety Movement Foundation Announces Dates and Speaker Line-up for 8th Annual World Patient Safety, Science & Technology Summit

3 years ago

Event Brings Together Key Industry Leaders and Healthcare Organizations to Confront Leading Patient Safety Issues IRVINE, Calif.--(BUSINESS WIRE)--#0X2030--The Patient Safety…

GE Healthcare Receives FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery

3 years ago

End-tidal Control software helps reduce greenhouse gas emissions and costs by cutting anesthetic agent waste Enables anesthesia providers to set…

SecurAcath® Receives Innovative Technology Contract From Vizient

3 years ago

PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces its SecurAcath device has received an Innovative Technology contract…

Axonics® Launches Direct to Consumer Television Advertising Campaign

3 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

Kareo and PatientPop’s Combined Platform Leveraged by the Perdido Bay Medical Group to Deliver Integrated Care and Grow Business

3 years ago

All-in-One Solution Boosts Operations and Digital Footprint for New Practice in Alabama IRVINE, Calif.--(BUSINESS WIRE)--#Kareo--Kareo, a leading provider of cloud-based…

BridgeBio Pharma Presents Updated Results from Phase 2 Open-label Extension Study of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

3 years ago

- NT-proBNP, a biomarker of cardiac failure and independent predictor of mortality in ATTR-CM patients, was stable or improving throughout…